These signaling pathways may play a part in treating obesity by the molecular mechanism underlying Prosaponinogen D. Prosapogenin D was also selected for molecular docking with regulatory proteins in the PI3K-Akt signaling pathway to provide more in-depth research in this study. The gene discussed is AKT1; the disease is obesity disorder.